A cornerstone of heart failure treatment is not effective in experimental right ventricular failure

International Journal of Cardiology

Volumn 169, Issue 3, 2013, Pages 183-189

  Borgdorff, Marinus A ^a   Bartelds, Beatrijs ^a   Dickinson, Michael G ^a   Steendijk, Paul ^b   Berger, Rolf M F ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fibrosis; Maladaptation; Pressure volume loops; Pulmonary artery banding; RAAS system; Right ventricular failure

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; EPLERENONE; LOSARTAN; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; DRUG EFFECT; ECHOCARDIOGRAPHY; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART OUTPUT; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE PRESSURE; HEART STROKE VOLUME; HEART VENTRICLE ENDDIASTOLIC PRESSURE; LIVER CONGESTION; LUNG ARTERY BANDING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SHAM PROCEDURE; SURVIVAL;

FIBROSIS; MALADAPTATION; PRESSURE-VOLUME LOOPS; PULMONARY ARTERY BANDING; RAAS SYSTEM; RIGHT VENTRICULAR FAILURE;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; HEART FAILURE; LOSARTAN; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR; SPIRONOLACTONE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84887624381     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.08.102     Document Type: Article

References (54)

1. K. Norozi, A. Wessel, and V. Alpers Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery Am J Cardiol 97 2006 1238 1243
2. T.P. Graham Jr., Y.D. Bernard, and B.G. Mellen Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study J Am Coll Cardiol 36 2000 255 261
3. M.A. Fogel, and J. Rychik Right ventricular function in congenital heart disease: pressure and volume overload lesions Prog Cardiovasc Dis 40 1998 343 356
4. O. Sitbon, M. Humbert, and H. Nunes Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival J Am Coll Cardiol 40 2002 780 788
5. N.F. Voelkel, R.A. Quaife, and L.A. Leinwand National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure Circulation 114 2006 1883 1891
6. S.A. Hunt, W.T. Abraham, and M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 e391 e479
7. J.J. McMurray, S. Adamopoulos, and S.D. Anker ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 14 2012 803 869
8. F. Haddad, S.A. Hunt, D.N. Rosenthal, and D.J. Murphy Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle Circulation 117 2008 1436 1448
9. F. Haddad, R. Doyle, D.J. Murphy, and S.A. Hunt Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure Circulation 117 2008 1717 1731
10. S. Zaffran, R.G. Kelly, S.M. Meilhac, M.E. Buckingham, and N.A. Brown Right ventricular myocardium derives from the anterior heart field Circ Res 95 2004 261 268
11. B. Bartelds, M.A. Borgdorff, and A. Smit-van Oosten Differential responses of the right ventricle to abnormal loading conditions in mice: pressure vs. volume load Eur J Heart Fail 13 2011 1275 1282
12. E.N. Olson Gene regulatory networks in the evolution and development of the heart Science 313 2006 1922 1927
13. H.C. Champion, E.D. Michelakis, and P.M. Hassoun Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications Circulation 120 2009 992 1007
14. M.L. Handoko, F.S. de Man, C.P. Allaart, W.J. Paulus, N. Westerhof, and A. Vonk-Noordegraaf Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: lessons from the left heart Eur Respir Rev 19 2010 72 82
15. G.M. Kuster, E. Kotlyar, and M.K. Rude Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload Circulation 111 2005 420 427
16. D. Fraccarollo, P. Galuppo, S. Hildemann, M. Christ, G. Ertl, and J. Bauersachs Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction J Am Coll Cardiol 42 2003 1666 1673
17. E.O. Weinberg, F.J. Schoen, and D. George Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis Circulation 90 1994 1410 1422
18. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators N Engl J Med 325 1991 293 302
19. B. Pitt, W. Remme, and F. Zannad Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
20. A.P. Bolger, R. Sharma, and W. Li Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease Circulation 106 2002 92 99
21. S.J. Hechter, P.M. Fredriksen, and P. Liu Angiotensin-converting enzyme inhibitors in adults after the Mustard procedure Am J Cardiol 87 2001 660 663 [A11]
22. J. Therrien, Y. Provost, J. Harrison, M. Connelly, H. Kaemmerer, and G.D. Webb Effect of angiotensin receptor blockade on systemic right ventricular function and size: a small, randomized, placebo-controlled study Int J Cardiol 129 2008 187 192
23. A. Dore, C. Houde, and K.L. Chan Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial Circulation 112 2005 2411 2416
24. S.J. Lester, D.B. McElhinney, and E. Viloria Effects of losartan in patients with a systemically functioning morphologic right ventricle after atrial repair of transposition of the great arteries Am J Cardiol 88 2001 1314 1316
25. T. van der Bom, M.M. Winter, and B.J. Bouma Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial Circulation 127 2013 322 330
26. M.M. Winter, B.J. Bouma, and M. Groenink Latest insights in therapeutic options for systemic right ventricular failure: a comparison with left ventricular failure Heart 95 2009 960 963
27. M.A. Borgdorff, B. Bartelds, and M.G. Dickinson Sildenafil enhances systolic adaptation, but does not prevent diastolic dysfunction, in the pressure-loaded right ventricle Eur J Heart Fail 14 2012 1067 1074
28. X. Xu, W. Wan, and L. Ji Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats Cardiovasc Res 78 2008 523 532
29. P. Vavrinec, R.P. van Dokkum, M. Goris, H. Buikema, and R.H. Henning Losartan protects mesenteric arteries from ROS-associated decrease in myogenic constriction following 5/6 nephrectomy J Renin Angiotensin Aldosterone Syst 12 2011 184 194
30. D. Fraccarollo, P. Galuppo, I. Schmidt, G. Ertl, and J. Bauersachs Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction Cardiovasc Res 67 2005 97 105
31. S. Brimioulle, P. Wauthy, and P. Ewalenko Single-beat estimation of right ventricular end-systolic pressure-volume relationship Am J Physiol Heart Circ Physiol 284 2003 H1625 H1630
32. M.E. van Albada, G.J. du Marchie Sarvaas, J. Koster, M.C. Houwertjes, R.M. Berger, and R.G. Schoemaker Effects of erythropoietin on advanced pulmonary vascular remodelling Eur Respir J 31 2008 126 134
33. L. Li, N. Zhou, and H. Gong Comparison of angiotensin II type 1-receptor blockers to regress pressure overload-induced cardiac hypertrophy in mice Hypertens Res 33 2010 1289 1297
34. O.H. Cingolani, N.G. Perez, and I.L. Ennis In vivo key role of reactive oxygen species and NHE-1 activation in determining excessive cardiac hypertrophy Pflugers Arch 462 2011 733 743
35. T.E. Christoffersen, M. Aplin, and C.C. Strom Increased natriuretic peptide receptor A and C gene expression in rats with pressure-overload cardiac hypertrophy Am J Physiol Heart Circ Physiol 290 2006 H1635 H1641
36. H.A. Rockman, S.P. Wachhorst, L. Mao, and J. Ross Jr. ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice Am J Physiol 266 1994 H2468 H2475
37. V. Franco, Y.F. Chen, and J.A. Feng Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice Clin Exp Pharmacol Physiol 33 2006 773 779
38. A. Andersen, J.M. Nielsen, C.D. Peters, U.K. Schou, E. Sloth, and J.E. Nielsen-Kudsk Effects of phosphodiesterase-5 inhibition by sildenafil in the pressure overloaded right heart Eur J Heart Fail 10 2008 1158 1165
39. H.J. Bogaard, R. Natarajan, and S.C. Henderson Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure Circulation 120 2009 1951 1960
40. M.J. Faber, M. Dalinghaus, and I.M. Lankhuizen Right and left ventricular function after chronic pulmonary artery banding in rats assessed with biventricular pressure-volume loops Am J Physiol Heart Circ Physiol 291 2006 H1580 H1586
41. M. Koide, B.A. Carabello, and C.C. Conrad Cooper G,4th, Zile MR. Hypertrophic response to hemodynamic overload: role of load vs. renin-angiotensin system activation Am J Physiol 276 1999 H350 H358
42. J.L. Rouleau, G. Kapuku, and S. Pelletier Cardioprotective effects of ramipril and losartan in right ventricular pressure overload in the rabbit: importance of kinins and influence on angiotensin II type 1 receptor signaling pathway Circulation 104 2001 939 944
43. J.L. Segar, T.D. Scholz, K.A. Bedell, O.M. Smith, D.J. Huss, and E.N. Guillery Angiotensin AT1 receptor blockade fails to attenuate pressure-overload cardiac hypertrophy in fetal sheep Am J Physiol 273 1997 R1501 R1508
44. M.U. Braun, P. Szalai, R.H. Strasser, and M.M. Borst Right ventricular hypertrophy and apoptosis after pulmonary artery banding: regulation of PKC isozymes Cardiovasc Res 59 2003 658 667
45. K. Asano, D.L. Dutcher, and J.D. Port Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium Circulation 95 1997 1193 1200
46. E.O. Weinberg, M.A. Lee, and M. Weigner Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis Circulation 95 1997 1592 1600
47. K.M. Baker, M.I. Chernin, S.K. Wixson, and J.F. Aceto Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats Am J Physiol 259 1990 H324 H332
48. J.J. Lopez, B.H. Lorell, and J.R. Ingelfinger Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts Am J Physiol 267 1994 H844 H852
49. J. Habibi, V.G. DeMarco, and L. Ma Mineralocorticoid receptor blockade improves diastolic function independent of blood pressure reduction in a transgenic model of RAAS overexpression Am J Physiol Heart Circ Physiol 300 2011 H1484 H1491
50. J.A. Johnson, J. West, K.B. Maynard, and A.R. Hemnes ACE2 improves right ventricular function in a pressure overload model PLoS One 6 2011 e20828
51. M. Okada, T. Harada, R. Kikuzuki, H. Yamawaki, and Y. Hara Effects of telmisartan on right ventricular remodeling induced by monocrotaline in rats J Pharmacol Sci 111 2009 193 200
52. F.S. de Man, L. Tu, and M.L. Handoko Dysregulated renin-angiotensin- aldosterone system contributes to pulmonary arterial hypertension Am J Respir Crit Care Med 186 2012 780 789
53. B. Rondelet, F. Kerbaul, and R. Van Beneden Prevention of pulmonary vascular remodeling and of decreased BMPR-2 expression by losartan therapy in shunt-induced pulmonary hypertension Am J Physiol Heart Circ Physiol 289 2005 H2319 H2324
54. M.A. Borgdorff, B. Bartelds, M.G. Dickinson, P. Steendijk, M. de Vroomen, and R.M. Berger Distinct loading conditions reveal various patterns of right ventricular adaptation Am J Physiol Heart Circ Physiol 305 2013 H354 H364